Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (557)	1/16/2002 1:14:54 PM
From: tuck	Read Replies (1) of 1005

>>I suspect this run for INGN will run out of steam after this PR blitz. Best to swing trade these puppies. BLUE HP sells out: 1000 shares at $6.07, the bid as I type.<< Well, I got this one right, anyhow. It got bid up on progress, but at the end of the day, the market still loves to hate gene therapy and vaccine companies. Despite the added "value," INGN has given back most of its gains. BLUE HP still has hope for the gene therapy companies, and so begins nibbling on INGN again because it seems to be presenting an attractive entry point. 500 shares @ current ask of $4.85. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next